Idarubicin
- TRADE NAMES: Idamycin (Pfizer); Zavedos
- INDICATIONS: Acute myeloid leukemia
- SYNONYM: 4-demethoxydaunorubicin; 4-DMDR
- CLASS: Antibiotic, Antibiotic; anthracycline, Antimicrobial
- HALF-LIFE: 14–35 hours (oral)
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
OCULAR.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric